Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic tool improves the study of hair growth and potential hair disorder treatments.

Applying calreticulin can speed up wound healing in diabetics.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

A specific DNA region controls skin cell gene expression by working with certain proteins.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Human hair keratins K85 and K35 create unique filament patterns important for early hair formation.

Human keratinocytes do not naturally respond to androgens.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

CTP-543 is generally safe for treating alopecia areata.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The prototype for analyzing skin aging works technically and clinically.

Dual TCR Treg cells are common in mouse tissues and vary by location.

WRKY transcription factors help plants manage stress and support growth.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.